These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Antiviral drugs in the immunocompetent host: part I. Treatment of hepatitis, cytomegalovirus, and herpes infections. Colgan R; Michocki R; Greisman L; Moore TA Am Fam Physician; 2003 Feb; 67(4):757-62, 675. PubMed ID: 12613729 [TBL] [Abstract][Full Text] [Related]
49. Nuclear war against herpesviruses. Hovi T Med Biol; 1980 Feb; 58(1):5-7. PubMed ID: 6247587 [No Abstract] [Full Text] [Related]
50. [New aspects in the diagnosis and treatment of herpes infections]. Heimdahl A; Abele G; Harmenberg J; Zetterqvist L Tandlakartidningen; 1986 Sep; 78(17):865-9, 871-3. PubMed ID: 3024345 [No Abstract] [Full Text] [Related]
51. Advances in the antiviral therapy of herpes virus infection in children. Luck S; Sharland M; Griffiths P; Jenkins SM Expert Rev Anti Infect Ther; 2006 Dec; 4(6):1005-20. PubMed ID: 17181417 [TBL] [Abstract][Full Text] [Related]
53. Aranucleosides and aranucleotides in viral chemotherapy. North TW; Cohen SS Pharmacol Ther; 1979; 4(1):81-108. PubMed ID: 88745 [No Abstract] [Full Text] [Related]
54. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication. Sloan BJ; Kielty JK; Miller FA Ann N Y Acad Sci; 1977 Mar; 284():60-80. PubMed ID: 212990 [TBL] [Abstract][Full Text] [Related]
55. Research in the field of antiviral chemotherapy performed in the "Stefan S. Nicolau" Institute of Virology. Eşanu V Virologie; 1984; 35(4):281-93. PubMed ID: 6097022 [TBL] [Abstract][Full Text] [Related]